MERS-CoV Genomic Surveillance Remains Heavily Skewed Toward the Arabian Peninsula
Publicly available MERS-CoV genomes paint an uneven picture of one of the world’s most persistent zoonotic threats. A global analysis of 807 human- and camel-derived sequences collected from 2012 through 2024 shows a surveillance system concentrated in a narrow geographic band, with most genomes originating from Saudi Arabia and the United Arab Emirates while large regions with substantial camel populations remain sparsely sampled.
The pattern is not merely academic. When the genomic record is concentrated in a few countries, it becomes much harder to judge where the virus is circulating, how often it spills over into humans, and whether regional lineages are spreading quietly beyond the places where testing is most intense. For a pathogen with epidemic potential, incomplete visibility becomes its own hazard.
Middle East respiratory syndrome coronavirus first emerged in humans in 2012 and continues to draw attention because of its severity, its camel reservoir, and the absence of licensed vaccines or therapeutics. Human infection remains relatively uncommon compared with the scale of camel exposure, but when infection occurs it can be devastating, with a crude case-fatality ratio of approximately 37% cited in the report. Most human cases remain linked directly or indirectly to dromedary camels, making animal surveillance inseparable from human surveillance.
A Curated Global Dataset Still Leaves Major Blind Spots
Investigators initially retrieved 1,738 MERS-CoV sequence records from GenBank and then narrowed the analysis to human- and camel-derived sequences that met quality thresholds. Sequences with more than 10% ambiguous bases or shorter than 15,000 nucleotides were excluded, leaving a curated dataset used for downstream analyses. Collection and submission metadata were supplemented where possible through published literature and public reports, a reminder that even the most basic data fields are often incomplete in public repositories.
The geographic imbalance was stark. The abstract identifies major gaps across Africa and South and Central Asia despite large camel populations, active trade, and evidence of viral circulation. Those omissions matter because MERS-CoV ecology is not uniform. In the Arabian Peninsula, clade B predominates and has been associated with repeated spillover into humans. In East Africa, clade C predominates in camels. The clade pattern is biologically and epidemiologically meaningful because it reflects regional virus ecology, host exposure, and potentially differences in viral behavior that are still being explored.
One sentence captures the operational problem with unusual clarity: the available genome set does not match the geography of risk.
Clade Patterns Track Regional Ecology, Not Just Sampling Habits
Phylogenetic analysis confirmed the predominance of clade B in the Arabian Peninsula and clade C in East Africa, consistent with known regional patterns. The study also notes recent detection of clade B sequences in camels from Africa, a finding that raises the possibility of broader geographic movement or shifting viral ecology. Because the report focused on public genomic data as a surveillance resource rather than on reconstructing transmission chains or estimating evolutionary rates, the emphasis stayed on what the data can support: broad situational awareness, not fine-grained outbreak tracing.
That distinction matters in public health practice. A genome tree can reveal where lineages cluster and how they are distributed across hosts and countries, but it cannot compensate for absent samples. If the sequence archive underrepresents Africa, South Asia, or Central Asia, then phylogenetic conclusions from those regions will inevitably be thinner and less stable than conclusions drawn from Saudi Arabia or the United Arab Emirates.
The biological context adds urgency. MERS-CoV belongs to the Merbecovirus subgenus within Betacoronavirus, the same broader viral family that includes SARS-CoV and SARS-CoV-2. Seasonal spillover from camels has been considered plausible, especially after the camel calving season when maternally derived immunity in young animals wanes and susceptibility rises. Ex vivo work has suggested that clades may differ in replication efficiency and host-cell entry, which could help explain why regional patterns differ, though those mechanisms remain under study.
Metadata Gaps and Submission Delays Reduce Public Health Value
The surveillance weaknesses extend well beyond geography. The analysis found incomplete metadata and long delays between sample collection and public sequence submission, often spanning years. In a pathogen with ongoing zoonotic spillover, that lag strips genomic data of much of its operational value. A sequence submitted years after collection may still be useful for evolutionary context, but it is far less useful for real-time risk assessment, field response, or prioritization of animal and human surveillance.
Timeliness was therefore treated as an operational indicator rather than a virologic feature. The study calculated turnaround time as the interval between collection and public submission, excluding sequences without complete date metadata. In public health terms, delayed sharing creates a situation where the sequence archive is historically rich but tactically thin. The virus continues to circulate while the data trail arrives late.
The problem is amplified by uneven host representation. Human and camel sequences together help define the zoonotic interface, but the utility of that interface depends on the completeness of accompanying information. Host species, country of origin, and collection date are not cosmetic fields; they determine whether a genome can be interpreted in context. Missing annotations make it harder to connect a sequence to animal movement, spillover risk, and changing regional transmission patterns.
One Health Surveillance Needs Better Geographic Balance and Faster Sharing
The report argues for integrating genomic data with population and trade information to support more representative One Health surveillance. Camel population and movement data from FAOSTAT were used to contextualize genomic sampling density, helping expose where sequence coverage appears sparse relative to camel density and trade connectivity. The logic is straightforward: places with large camel populations and active movement networks deserve more than sporadic genomic sampling if the goal is early warning.
This is where the study has practical relevance for field surveillance. A sequence archive dominated by a few countries can still support global comparisons, but it cannot reliably reveal whether viral circulation is broadening, whether lineages are moving across borders, or whether newly detected clades reflect true emergence versus delayed discovery. For MERS-CoV, where the animal reservoir is large and human disease can be severe, those blind spots are not trivial.
The analysis also reinforces a familiar lesson from zoonotic surveillance. Genomic data are most useful when they are timely, representative, and richly annotated. Remove any one of those elements, and the value drops quickly. Remove two, and the system becomes little more than a retrospective archive.
What remains unresolved is not whether MERS-CoV continues to circulate, but how much of that circulation is still invisible to the public record. The study leaves that question open by design, while making the weakness of the current genomic picture impossible to miss.